GlassScriptPhysician profile
Rashmi Bolinjkar
NPI 1518271543
$376.94
in general payments reported to CMS, 2019-2025
13 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2022: $92.34 · 2023: $47.26 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $49.76 | 2022 | |
| Hologic Sales and Service, LLC | $48.91 | 2023-2025 | Acessa Provu System, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Intuitive Surgical, INC. | $42.58 | 2022 | |
| Vertical Pharmaceuticals, LLC | $41.67 | 2019 | |
| Astellas Pharma US INC | $32.58 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $25.99 | 2023 | |
| Pfizer INC. | $25.30 | 2025 | |
| Millicent US INC | $22.68 | 2019 | |
| Organon LLC | $21.58 | 2025 | Jada System |
| Coopersurgical, INC. | $17.93 | 2019 | |
| Glaxosmithkline, LLC. | $17.64 | 2025 | Shingrix |
| Boston Scientific Corporation | $16.96 | 2019 | |
| Therapeuticsmd, INC. | $13.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashmi Bolinjkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.